抗抑郁药处方未充分反映累积网络荟萃分析与指南推荐的证据演变
每5年进行一次网络荟萃分析(NMAs),并提取CPGs推荐及5年间隔处方调查。发现CPG推荐多为药物类别而非个体药物,而NMAs显示同类药物间存在显著差异;处方变化与CPGs更新或NMAs效应变化不相应。
要点
- CPG推荐多针对药物类别,但NMAs显示同类药物间疗效和可接受性存在差异。
- 所有CPGs更新间隔均超过5年,处方变化与指南更新或NMAs证据变化不匹配。
- 未来应加速CPG更新并监测营销对处方的影响。
核心结论
- 抗抑郁药处方变化未充分反映累积网络荟萃分析和指南推荐的证据演变。
研究设计与样本
- 每5年进行一次抗抑郁药网络荟萃分析(至2016年),基于双盲随机对照试验综合数据集。
- 识别临床实践指南并提取推荐,调查美国5年间隔处方(至2015年)。
主要发现
- CPG推荐的大多数药物在NMAs中疗效和可接受性表现良好。
- CPG推荐常以药物类别而非个体药物形式给出,而NMAs提示同类药物间存在显著差异。
- 所有CPGs更新间隔均超过5年。
- 美国频繁处方的所有抗抑郁药均被CPGs推荐。
- 处方变化与CPGs更新或NMAs显示的效应明显变化不相应。
临床怎么用
- 临床应关注CPG推荐中药物类别与个体药物证据的差异,结合NMAs结果优化个体化用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study compares three major elements of evidence-based medicine (EBM) practices, namely evidence synthesis, clinical practice guidelines (CPGs), and real-world prescriptions in the United States, regarding antidepressant treatments of major depression over the past 3 decades. STUDY DESIGN AND SETTING: We conducted network meta-analyses (NMAs) of antidepressants every 5 years up to 2016 based on a comprehensive data set of double-blind randomized controlled trials. We identified CPGs and extracted their recommendations. We surveyed the prescriptions in the United States at 5-year intervals up to 2015. RESULTS: Most drugs recommended by CPGs presented favorable performance in efficacy and acceptability in NMAs. However, CPG recommendations were often in terms of drug classes rather than individual drugs, whereas NMAs suggested distinctive difference between drugs within the same class. The update intervals of all CPGs were longer than 5 years. All the antidepressants prescribed frequently in the United States were recommended by CPGs. However, changes in prescriptions did not correspond to alterations in CPGs or to apparent changes in the effects indicated by NMAs. Many factors including marketing efforts, regulations, or patient values may have played a role. CONCLUSION: Enhancements including accelerating CPG updates and monitoring the impact of marketing on prescriptions should be considered in future EBM implementation.
引用
- Luo Y, Ostinelli EG, Sahker E, et al. Antidepressant prescriptions have not fully reflected evolving evidence from cumulative network meta-analyses and guideline recommendations. J Clin Epidemiol. 2021. PMID: 33359320. doi:10.1016/j.jclinepi.2020.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。